会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • NITRIC OXIDE INHALATION THERAPY FOR INFANTS WITH BRONCHIOLITIS
    • 含有BRONCHIOLITIS的婴儿的氮氧化物吸入治疗
    • WO2017042636A1
    • 2017-03-16
    • PCT/IB2016/001447
    • 2016-09-09
    • ADVANCED INHALATION THERAPIES (AIT) LTD.
    • AV-GAY, YossefGREENBERG, DavidTAL, Asher
    • A61P9/00A61K31/198
    • A61K33/00A61K2300/00
    • The present invention provides a method for treating bronchiolitis in an infant in need thereof, wherein the method comprises repeatedly administering to the infant a gas mixture comprising nitric oxide at a concentration from about 144 to about 176 ppm for a first period of time, followed by a gas mixture containing no nitric oxide for a second period of time, wherein the administration is repeated for a time sufficient to: a) reduce the length of time of hospitalization required to achieve oxygen saturation greater than or equal to 92% in room air; b) reduce the length of time of hospitalization required to achieve a clinical score of less than or equal to 5; c) reduce the length of time of hospitalization required to be discharged; or d) any combination thereof, as compared to an infant that is not subjected to the repeated administration of nitric oxide.
    • 本发明提供了治疗有需要的婴儿的细支气管炎的方法,其中所述方法包括向婴儿反复施用含有浓度为约144至约176ppm的一氧化氮的气体混合物,持续第一时间段,随后是 在第二时间段内不含一氧化氮的气体混合物,其中重复给药足够的时间:a)在室内空气中减少达到氧饱和度所需的时间长度大于或等于92%; b)减少实现临床评分小于或等于5的住院时间; c)减少需要出院的住院时间; 或d)与未经受重复施用一氧化氮的婴儿相比的任何组合。
    • 4. 发明申请
    • METHODS OF TREATMENT OF RESPIRATORY TRACT INFECTIONS AND CYSTIC FIBROSIS
    • 呼吸道感染和囊性纤维化的治疗方法
    • WO2017130066A1
    • 2017-08-03
    • PCT/IB2017/000118
    • 2017-01-27
    • ADVANCED INHALATION THERAPIES (AIT) LTD.
    • GREENBERG, DavidTAL, AsherAV-GAY, Yossef
    • A61K33/00
    • A61K33/00A61K31/04
    • The present invention provides a method for treating cystic fibrosis in a human subject in need thereof, wherein the method comprises repeatedly administering to the human subject a gas mixture comprising nitric oxide at a concentration from about 144 to about 176 ppm for a first period of time, followed by a gas mixture containing no nitric oxide for a second period of time, wherein the administration is repeated for a time sufficient to: a) reduce the level of at least one inflammatory biomarker in the human subject when compared to the level of the inflammatory biomarker prior to the administration; b) reduce the microbial density by 1 to 2 log units as measured by colony forming units in the human subject when compared to the microbial density prior to the administration; or c) a combination thereof.
    • 本发明提供了治疗有此需要的人类受试者中的囊性纤维化的方法,其中所述方法包括向人类受试者重复施用包含一氧化氮浓度为约144至约 在第一段时间内接触176ppm,随后在第二段时间内不含一氧化氮的气体混合物,其中给药重复足够的时间以:a)降低人体中至少一种炎性生物标志物的水平 当与施用前的炎性生物标志物的水平相比较时受试者; b)当与施用前的微生物密度相比时,通过人类受试者中的菌落形成单位测量,将微生物密度降低1至2个对数单位; 或c)其组合。